Merus Labs International Inc.

Merus Labs International Inc. is a specialty pharmaceutical company engaged in the acquisition and licensing of niche pharmaceutical products throughout North America. By capitalizing on its expertise of the North American pharmaceutical markets and access to capital, Merus is currently focused on building its portfolio of products. Merus strategically develops the sale and distribution of their product line by introducing a targeted re-launch marketing and promotional plan. PowerOne was instrumental in the creation of the company and has helped Merus raise over $100M in Debt and Equity since its inception.

Visit Website

Transactions

News

April 30, 2015 An anonymous director reports MERUS LABS INTERNATIONAL INC ANNOUNCES CLOSING OF C$600 MILLION BOUGHT DEAL FINANCING Merus Labs International Inc has closed its previously...

June 10, 2013 Merus Labs International Inc ("Merus" or the "Company") (TSX:MSL) (NASDAQ:MSLI) announces that it has completed its previously announced non-brokered private placement financing (the...

VANCOUVER, Oct 14, 2011 /CNW/ - Merus Labs International Inc (the "Company") is pleased to announce that 16,324,250 warrants were exercised pursuant to the warrant incentive program (the "Program")...

March 23, 2011 VANCOUVER, March 23 /CNW/ - Merus Labs International Inc ("Merus" or the "Company") is pleased to announce that it has closed the previously announced non-brokered private placement...